Updated Jul 16, 2026
Sailer Carl has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Carl Sailer is listed as a director of Acurx Pharmaceuticals, Inc. in the company’s SEC filings, with the most recent filing dated 2026-04-22. Based on this context, he serves on the board of a publicly traded biotech company, providing governance oversight and contributing to strategic and fiduciary decision-making. Public disclosures identify him as a director for Acurx Pharmaceuticals, illustrating formal board-level responsibility within the organization.
| Role | Director |
|---|---|
| Notability | 60/100 |
Carl Sailer is listed as a director of Acurx Pharmaceuticals, Inc. in the company’s SEC filings, with the most recent filing dated 2026-04-22. Based on this context, he serves on the board of a publicly traded biotech company, providing governance oversight and contributing to strategic and fiduciary decision-making. Public disclosures identify him as a director for Acurx Pharm…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sailer Carl profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.